DOW JONES26,319.58-638.01 -2.37%
S&P 5003,042.38-74.01 -2.37%
NASDAQ8,698.09-282.68 -3.15%

Cowen & Co. Maintains Outperform on Teladoc Health, Raises Price Target to $100

Cowen & Co. analyst Charles Rhyee maintains Teladoc Health (NYSE:TDOC) with a Outperform and raises the price target from $86 to $100.

Benzinga · 01/13/2020 14:18

Cowen & Co. analyst Charles Rhyee maintains Teladoc Health (NYSE:TDOC) with a Outperform and raises the price target from $86 to $100.